Andreas Halvorsen’s Salix Pharmaceuticals SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Andreas Halvorsen's SLXP Position: Q1 2015 in Review
Andreas Halvorsen sold out of Salix Pharmaceuticals (SLXP) in Q1 2015, closing a stake of 1,738,104 shares — an estimated $200M sold.
Andreas Halvorsen first reported a position in SLXP in Q1 2014 and held it in 4 quarters. The position peaked at $425M in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.
- Andreas Halvorsen reported no remaining Salix Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- Andreas Halvorsen sold 1,738,104 Salix Pharmaceuticals shares in Q1 2015, an estimated $200M.
- Andreas Halvorsen first reported a position in Salix Pharmaceuticals in Q1 2014 and held it in 4 quarters.
- Andreas Halvorsen's Salix Pharmaceuticals position peaked at $425M in Q3 2014.
- 298 funds tracked by Wall St. Rank held Salix Pharmaceuticals as of Q1 2015.
Based on Viking Global Investors's 13F filing for Q1 2015, filed 15 May 2015.